{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:20Z","timestamp":1786120220465,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/inf.0b013e31822a8541","type":"journal-article","created":{"date-parts":[[2011,8,4]],"date-time":"2011-08-04T12:14:10Z","timestamp":1312460050000},"page":"e235-e243","source":"Crossref","is-referenced-by-count":25,"title":["Response to Primary and Booster Vaccination With 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Korean Infants"],"prefix":"10.1097","volume":"30","author":[{"given":"Chang-Hwi","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Ho","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Nam","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Duck","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Yil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwang Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang","family":"Hyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Yun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Fanic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Borys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ruiz-Gui\u00f1az\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lode","family":"Schuerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Hyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-39-20210202","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1016\/j.vaccine.2009.09.111","article-title":". Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease.","volume":"27","author":"Hausdorff","year":"2009","journal-title":"Vaccine"},{"key":"R2-39-20210202","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3201\/eid1402.070807","article-title":". Streptococcus pneumoniae serotype 19A in children, South Korea.","volume":"14","author":"Choi","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"R3-39-20210202","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/AAC.48.6.2101-2107.2004","article-title":". High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study).","volume":"48","author":"Song","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R4-39-20210202","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/AAC.00966-09","article-title":". Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance.","volume":"54","author":"Bae","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R5-39-20210202","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/INF.0b013e3181f2da06","article-title":". Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with DTPw-HBVHib and poliovirus vaccines.","volume":"30","author":"Bermal","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R6-39-20210202","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/INF.0b013e318199f901","article-title":". The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBVHib and poliovirus vaccines: assessment of immunogenicity.","volume":"28","author":"Bermal","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R7-39-20210202","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/INF.0b013e318199f62d","article-title":". Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.","volume":"28","author":"Chevallier","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R8-39-20210202","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(09)61208-3","article-title":". Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.","volume":"374","author":"Prymula","year":"2009","journal-title":"Lancet"},{"key":"R9-39-20210202","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1097\/INF.0b013e3181b48ca3","article-title":". Immunogenicity of a 2-dose priming and booster vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine.","volume":"28","author":"Silfverdal","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R10-39-20210202","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":". Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R11-39-20210202","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/INF.0b013e318199f609","article-title":". Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different Neisseria meningitidis serogroup C conjugate vaccines.","volume":"28","author":"Wysocki","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R12-39-20210202","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/INF.0b013e3181dffabf","article-title":". Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months.","volume":"29","author":"Vesikari","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R13-39-20210202","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1128\/IAI.67.6.2746-2762.1999","article-title":". Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection.","volume":"67","author":"Bakaletz","year":"1999","journal-title":"Infect Immun"},{"key":"R14-39-20210202","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1016\/j.vaccine.2006.03.021","article-title":". Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae.","volume":"24","author":"Novotny","year":"2006","journal-title":"Vaccine"},{"key":"R15-39-20210202","first-page":"5748","article-title":"Hoet B, et al..","volume":"27","author":"Schuerman","year":"2009","journal-title":"Prevention of otitis media: now a reality Vaccine"},{"key":"R16-39-20210202","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":". Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"R17-39-20210202","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1586\/erv.09.113","article-title":"10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.","volume":"8","author":"Prymula","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"R18-39-20210202","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CDLI.8.2.266-272.2001","article-title":"Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay.","volume":"8","author":"Concepcion","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"R19-39-20210202","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/CVI.13.3.356-360.2006","article-title":". Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera.","volume":"13","author":"Henckaerts","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R20-39-20210202","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/CVI.00289-09","article-title":". Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines.","volume":"17","author":"Poolman","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R21-39-20210202","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CDLI.4.4.415-422.1997","article-title":". Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.","volume":"4","author":"Romero-Steiner","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"R22-39-20210202","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.vaccine.2006.09.029","article-title":". Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.","volume":"25","author":"Henckaerts","year":"2007","journal-title":"Vaccine"},{"key":"R23-39-20210202","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/infdis\/149.6.1034","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.","volume":"149","author":"Anderson","year":"1984","journal-title":"J Infect Dis"},{"key":"R24-39-20210202","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F","article-title":"Bootstrap confidence intervals: when, which, what A practical guide for medical statisticians.","volume":"19","author":"Carpenter","year":"2000","journal-title":"Stat Med"},{"key":"R25-39-20210202","doi-asserted-by":"crossref","first-page":"7858","DOI":"10.1016\/j.vaccine.2007.08.022","article-title":". Immunogenicity and safety of pneumococcal 7-valent conjugate vaccine (diphtheria CRM(197) protein conjugate; Prevenar) in Korean infants: differences that are found in Asian children.","volume":"25","author":"Kim","year":"2007","journal-title":"Vaccine"},{"key":"R26-39-20210202","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.inf.0000050459.74134.d5","article-title":". Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants.","volume":"22","author":"Puumalainen","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R27-39-20210202","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.diagmicrobio.2008.10.002","article-title":"Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.","volume":"63","author":"Bae","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R28-39-20210202","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.diagmicrobio.2010.10.019","article-title":". Comparison of genotypes of Streptococcus pneumoniae serotypes 6A and 6B before and after the introduction of PCV7 vaccination in Korea.","volume":"69","author":"Baek","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R29-39-20210202","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/315096","article-title":". Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants.","volume":"180","author":"Yu","year":"1999","journal-title":"J Infect Dis"},{"key":"R30-39-20210202","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/CVI.00344-08","article-title":". Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A.","volume":"16","author":"Lee","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"R31-39-20210202","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3346\/jkms.2010.25.1.90","article-title":". Immunogenicity of Haemophilus influenzae type b conjugate vaccines in Korean infants: a meta-analysis.","volume":"25","author":"Lee","year":"2010","journal-title":"J Korean Med Sci"},{"key":"R32-39-20210202","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/INF.0b013e318199f61b","article-title":". Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).","volume":"28","author":"Knuf","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R33-39-20210202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1586\/14760584.7.1.97","article-title":"Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates.","volume":"7","author":"Dagan","year":"2008","journal-title":"Expert Rev Vaccines"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e31822a8541","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:13:30Z","timestamp":1786047210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201112000-00039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31822a8541","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}